Data have previously been presented suggesting that a test based on the plasma cortisol response to insulin-induced hypoglycemia may be valuable in the diagnosis of patients with suspected hypothalamic or pituitary dysfunction (1). Further, the increased secretion of growth hormone that normally follows the injection of insulin (2-4) has been shown to be mediated via the hypothalamus (5) and to be impaired in children and adults with hypopituitarism (2, 4, 6, 7). These studies, which have been limited to small groups of patients, have not involved the simultaneous determination of both the plasma cortisol and the growth. hormone response and have not been related to other tests of pituitary or adrenal function.
Data have previously been presented suggesting that a test based on the plasma cortisol response to insulin-induced hypoglycemia may be valuable in the diagnosis of patients with suspected hypothalamic or pituitary dysfunction (1) . Further, the increased secretion of growth hormone that normally follows the injection of insulin (2) (3) (4) has been shown to be mediated via the hypothalamus (5) and to be impaired in children and adults with hypopituitarism (2, 4, 6, 7) . These studies, which have been limited to small groups of patients, have not involved the simultaneous determination of both the plasma cortisol and the growth. hormone response and have not been related to other tests of pituitary or adrenal function.
The object of the present investigation was to compare the plasma cortisol and growth hormone responses to insulin in patients with disorders of hypothalamic or pituitary function with the results obtained in control subjects, and to study the relative value of this procedure in relation to other tests of pituitary and adrenal function. The free fatty acid (FFA) response to insulin was followed in several patients because of the important role assigned to the pituitary in regulating their rate of turnover and plasma level (8) (9) (10) . Finally, patients with anorexia nervosa were studied because * Submitted for publication September 21, 1965 29) were considered to have a hypothalamic rather than a primary pituitary disorder because they had diabetes insipidus, which is seldom encountered in pituitary dysfunction other than after hypophysectomy (12) , and because they had secondary adrenocortical insufficiency despite a normal adrenal response to the infusion of lysine vasopressin. The use of lysine vasopressin in helping to differentiate hypothalamic from pituitary causes of secondary adrenocortical insufficiency has been described previously (13) . Patient 27 had initially presented with cutaneous and other manifestations of sarcoidosis, after which he developed diabetes insipidus and secondary hypogonadism. Patient 28 wvas a 17-year-old girl who had not grown since the age of I1, when she had developed diabetes insipidus during a probable attack of encephalitis. In addition she had primary amenorrhea and an absence of any secondary sexual characteristics. The etiology of the presumed hypothalamic defect in Patient 29 was not known. He had always been smaller than his contemporaries and had presented with the signs and symptoms of secondary hypogonadism.
14 to 16 hours before starting the test. All patients were injected intravenously with 0.10 U of insulin per kg body weight with the exception of the four patients with untreated acromegaly, who received 0.30 U per kg. These doses of insulin were used in an attempt to reproduce the plasma sugar response found in control subjects injected with 0.15 U per kg, and the interpretation of the results obtained in the present study has been based on comparison with those found iln these control subjects and reported previously (14) . The (14) .
Compared with the controls the mean plasma sugar value of 111 ± 11.8 mg per 100 ml in fasting patients with untreated acromegaly was significantly high (p < 0.01) and the mean value of 73 ± 10.5 mg per 100 ml in fasting patients with anorexia nervosa significantly low (p < 0.01). t The maximal value 0 to 120 minutes after the injection of insulin. § The maximal value 0 to 120 minutes after the injection of insulin less the resting value. had significantly elevated resting growth hormone levels as compared with the control group (p < 0.001). The patients with acromegaly who had been treated surgically had detectable levels of growth hormone that were, however, markedly lower than the values found in the untreated group. Only one of the three patients with hypothalamic dysfunction and three of the 18 remaining patients with pituitary hypofunction had detectable levels of growth hormone after overnight fasting.
The plasma sugar, FFA, cortisol, and growth hormone responses to insulin In patients with untreated acriomegaly. A summary of the results obtained in four patients with untreated acromegaly after the intravenous injection of 0.30 U per kg of insulin is compared in Table II with the results found in 28 control subjects given 0.15 U per kg (14) .
The patients showed marked insulin resistance in relation to their plasma sugar response. Thuts the mean minimum of the plasma sugar was higher 1 and the recovery index lower than the mean values found in the control group given one-half the dose of insulin. This was associated with a normal plasma cortisol response in all four patients. There was considerable disparity in their plasma FFA response to insulin (Figure 1) , which appeared to be related to the presence, or absence, of a growth hormone response. Thus in Patient 1, in whom the maximal growth hormone increment was above the normal range, the recovery index of the plasma FFA was high, whereas in Patients 3 and 4 in whom there was no rise in growth hormone levels during the test, plasma FFA levels failed to increase from the nadir. Patient 2 had normal growth hormone and FFA responses to insulin.
In patients with hypothalamic or pituitary hypofunction. The results obtained in this group of patients after the injection of 0.10 U per kg of insulin are given in Table III. The plasma sugar fell to a mean minimal value of 36 ± 8.3 mg per 100 ml, which is not significantly different from that found in control subjects given the same dose of insulin and reported previously (14) . After the initial fall, however, the plasma sugar failed to rise normally in several of the patients. Thus the mean recovery index of the group (217 ± 34) was significantly lower (p < 0.001) than the value found in control subjects given a similar dose of insulin and approximated the value found in the control group given 0.15 U per kg. The plasma sugar recovery index Table VI . Ideally a quantitative measurement is required both for the ability of the pituitary to synthesize each hormone and its ability to release normal amounts when required. The assessments shown vary in the extent to which they approach these ideals. The use of the term "secretion" in discussing assessments is subject to these provisos.
Growth hormone secretion was markedly increased in the patients with untreated acromegaly and was absent or impaired in the remaining pa Tables II  and III   27 28 29 markedly elevated in patients with acromegaly, this determination is of little diagnostic value in patients with hypothalamic or pituitary hypofunction because the majority of normal subjects at rest after overnight fasting also have undetectable growth hormone levels with the sensitivity of the method used, set at > 1 mpig per ml (14) .
Similarly the determination of resting plasma cortisol is of limited diagnostic use, many patients in our study having levels within the normal range. These findings emphasize the need to employ a procedure that stimulates pituitary secretion in investigating such patients.
Tests based on the blood sugar response to insulin have been widely used for this purpose. Thus patients with acromegaly have been shown to be resistant to the hypoglycemic action of insulin (17) ; the four patients with untreated acromegaly in the present study required 0.30 U of insulin per kg to produce a response similar to that found in control subjects given half this amount. The increased insulin sensitivity found in hypopituitarism (18) or hypothalamic dysfunction (19) would appear to be of less diagnostic value, since some patients in the present study, who had definite endocrine hypofunction, showed a normal plasma sugar response to insulin. A further disadvantage is that many factors other than pituitary and hypothalamic function influence this response. Thus a variety of clinical conditions, such as primary adrenocortical insufficiency and malnutrition, which enter into the differential diagnosis of hypopituitarism, also result in increased insulin sensitivity (18, 20) . The lack of specificity of the routine insulin-sensitivity test is overcome if simultaneous determinations of plasma cortisol and growth hormone levels are made, since their normal response depends on the integrity of the hypothalamus and pituitary.
Many clinicians are reluctant to perform insulin tolerance tests in patients suspected of having hypopituitarism (21) . In our experience the value of the present test far outweighs any possible risks provided that the safeguards outlined previously (14) ' are undertaken and that the amount of insulin injected is related to the tentative diagnosis.
In the cases of hypopituitarism studied the growth hormone response to insulin was absent or impaired. Growth hormone production, as assessed in the present investigation, was affected before that of any other pituitary hormone, and the findings of a normal growth hormone rise would appear to exclude a diagnosis of pituitary hypofunction except for the rare cases with a single pituitary hormone defect. The determination of growth hormone levels after the injection of insulin does not appear, however, to offer any advantage as compared with the measurement of resting values in the diagnosis of patients suspected of having acromegaly. Thus in the present study, as previously reported (22) , some acrornegalic patients responded with a further rise in growth hormone, whereas others did not.
Three of our patients were considered to have primary hypothalamic rather than a pituitary disorder. They showed increased sensitivity to the hypoglycemic action of insulin together with an impaired or absent cortisol and growth hormone response. The importance of the hypothalamus in controlling the release of growth hormone from the pituitary after the injection of insulin may be inferred from the demonstration that stalk secretion abolishes the growth hormone response to insulin (5), whereas destruction of the anterior part of the ventral hypothalamic nucleus in squirrel monkeys decreases the growth hormone response to hypoglycemia without affecting significantly the resting levels (23) . The finding that pituitary autotransplarntation in the rat results in a markedly reduced rate of growth (24) is also of significance to the present findings that the two patients with hypothalamic dysfunction dating from childhood were both dwarfed.
Graded hypophysectomy in the dog results in a sequential loss of pituitary function in which gonadotropin production is impaired before that of TSH, which is then followed by loss of ACTH production (25) . Similar findings have been reported in patients with a variety of pituitary lesions (26, '27) , although evidence of secondary adrenal impairment frequently precedes that of secondary hypothyroidism in patients with chromophobe adenomas (28) . On the basis of the present investigation the order in which the pituitary secretion of hormones is most commonly impaired, other than in acromegaly, is growth hor- mone, gonadotropins, ACTH, TSH, and ADH, respectively. However, this order may reflect the differences in the precision and sensitivity of the methods employed for each hormonal assessment. The patients with hypothalmic dysfunction differed from the pituitary group only 'in the frequency with which they had diabetes insipidus.
One patient in the present study (No. 26) appeared to have a single pituitary defect, a failure to produce ACTH. She presented with secondary adrenocortical insufficiency, having an adequate adrenal response to exogenous ACTH but no response to metyrapone or to insulin-induced hypoglycemia. Other pituitary function tests were normal, and she was unique among the patients with hypothalamic or pituitary hypofunction in having a normal growth hormone rise during her test. Two similar cases have been reported (29) who, despite an inability to produce ACTH, showed a normal growth hormone response to insulin.
Normally insulin administration is associated with a prompt fall of plasma F:FA values followed by their rapid return to, or above, preinsulin levels. In patients with hypothalamic or pituitary hypofunction the recovery phase of this response was found to be consistently and markedly impaired.
This difference from the control group appeared to provide a more sensitive index of hypofunction than did the extent or duration of the insulin-induced hypoglycemia, suggesting that plasma FFA levels are more directly and exclusively under pituitary control than plasma sugar levels. Pituitary fractions effective in mobilizing fatty acids from adipose tissue include growth hormone, ACTH, and TSH (3Q). The present findings support the view that in man growth hormone may be of major importance in this respect (31, 32 (33) . The measurement of the resting cortisol and growth hormone levels and their response to insulin appears to offer a simple means of differentiating these two conditions. Thus although both groups showed increased insulin sensitivity, the patients with anorexia nervosa had significantly elevated resting plasma cortisol and growth hormone values that increased normally during the test in three of the five subjects studied. The impaired response in the remaining patients suggests that prolonged starvation may result in some degree of pituitary depletion (34) 
Summary
The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin in 34 patients with hypothalamic or pituitary dysfunction or anorexia nervosa has been compared with the results found in control subjects.
Patients with acromegaly were insulin resistant, but showed a normal plasma cortisol response provided a large dose was used (0.30 U per kg). Some of these patients failed to show a growth hormone increment above their high resting levels during the test, and the free fatty acid response appeared to be related to the presence or absence of such a rise.
In all patients suspected of having hypothalamic or pituitary hypofunction (with the exception of one who had an isolated defect of adrenocorticotropin production) an impaired or absent growth hormone response to insulin' was obtained. In some patients this was the only endocrine abnormality detected. The impairment of growth hormone secretion after insulin is of diagnostic value, since the appearance of this abnormality appears to precede evidence of gonadotropin, adrenocorticotropin, thyroid-stimulating hormone, or antidiuretic hormone deficiency. The free fatty acid response to insulin in these patients showed a consistent delay in the recovery phase. This finding proved a more sensitive index of hypofunction than did the extent and degree of the plasma sugar changes and may be of diagnostic value in hospitals without access to growth hormone determinations. The determination of plasma cortisol values throughout the insulin test had less diagnostic significance than the determination of growth hormone or free fatty acid levels, but was of value in determining whether these patients required cortisol replacement therapy. It 
